Top officials from India's Narcotics Control Bureau (NCB) and the United States Office of National Drug Control Policy (ON DCP) convened in New Delhi on November 2 and 3 to strengthen bilateral counter-narcotics cooperation, intelligence sharing, and coordinated action. The meeting took place in the context of ongoing joint crackdowns by Indian and US drug law enforcement agencies against a cartel operating across continents.
The two-day meeting served to review the progress made in combating illicit drug trafficking under the India-US Drug Policy Framework. Priority areas for strengthening intelligence sharing, coordinated law enforcement action, precursor control, pharmaceutical supply chain integrity, and drug demand reduction were identified during the discussions.
India presented a three-year roadmap outlining a comprehensive strategy to combat the illicit narcotics trade, focusing on network-centric investigations, precursor control, financial investigations, prevention, and rehabilitation. The meeting also addressed current drug trafficking trends and emerging threats.
The US delegation, led by ONDCP's acting deputy director Debbie Seguin, emphasized the importance of the US-India bilateral cooperation in disrupting transnational drug trafficking networks and preventing the diversion of synthetic drugs and chemical precursors into global markets. The US Drug Czar underscored the need for a targeted strategy to counter the sophisticated multinational logistics enterprises involved in illicit narcotics trade.
The meetings underscored the importance of sustained institutional engagement, timely intelligence exchange, and coordinated action to address emerging narcotics threats and promote demand reduction. Both sides agreed to further share best practices in targeted law enforcement topics.
